Boothbay Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-150,000
Closed -$3.2M 1915
2025
Q3
$3.2M Buy
+150,000
New +$3.55M 0.08% 438
2024
Q1
Sell
-73,500
Closed -$2.3M 1540
2023
Q4
$2.3M Sell
73,500
-60,900
-45% -$1.45M 0.08% 429
2023
Q3
$2.8M Buy
+134,400
New +$3.65M 0.09% 383
2021
Q2
Sell
-678
Closed -$1.75M 1817
2021
Q1
$1.75M Buy
+678
New +$29.8K 0.09% 369
2020
Q4
Sell
-132
Closed -$545K 1208
2020
Q3
$545K Sell
132
-132
-50% -$5.7K 0.04% 618
2020
Q2
$1.28M Sell
264
-102
-28% -$4.9K 0.11% 310
2020
Q1
$1.55M Buy
366
+134
+58% +$5.52K 0.16% 195
2019
Q4
$992K Buy
+232
New +$10.1K 0.11% 318

Other funds holding ACAD